Advertising
Showing 1 to 15 of 25 entries
SELL

Company being taken over (by MDT-N) for a tax inversion and he sold it because the legislative agenda might change and tax inversion may not continue to be allowed. He would go back after the deal closes.

biotechnology / pharmaceutical
SELL

Medical devices. He sold it when they were acquired. Was a great performer. He is worried US government may ban these tax inversion strategies.

biotechnology / pharmaceutical
BUY

He is going to tender it to the Medtronic (MDT-N) offer. He likes the combined company and it will be a core holding for him. Likes the healthcare business and where they are in it. The combined company will have more clout in dealing with vendors and customers.

biotechnology / pharmaceutical
BUY

(Market Call Minute.) US healthcare stock. He likes the area and he likes the company. Buy it and hold.

biotechnology / pharmaceutical
BUY

Markets have run up so substantially last year that there are pockets of value but not a lot generally everywhere. He is hoping that Q1 provides some opportunities for him to enter into names that he wants to buy. If looking for companies that have stable like characteristics and generally grow slowly over time, these are the kinds of companies you want to own. He is adding this for new clients.

biotechnology / pharmaceutical
PAST TOP PICK

(Top Pick Dec 18/12, Up 30.11%) Economically sensitive because more employment means more health plans and more elective surgeries. Spun out a drug division and that helped his returns.

biotechnology / pharmaceutical
BUY

Buying for new clients. It is the largest hospital supply company. Operating room supplies, disposable. Economically sensitive. Operating rooms are used more when people can do elective surgeries – employed and with health insurance. 1.9% dividend. They want to increase their payout.

biotechnology / pharmaceutical
BUY

American company headquartered in Ireland for tax reasons. Hospital supply, surgical supplies. Goes up and down with the economy because with insurance when you are working you get more elective surgery. Bought when people were out of work and stock price was depressed. It was not a problem with the company but with the economy. Leader in its sector.

biotechnology / pharmaceutical
PAST TOP PICK

(A Top Pick July 27/12. Up 24.42%.) One of the things he liked is that it was US-based but Irish Incorporated for tax purposes. In the hospital supply business. Had a generic drug subsidiary, which was spun out to the shareholders at the end of June, which he sold as soon as he got it.

biotechnology / pharmaceutical
PAST TOP PICK

(A Top Pick July 13/12. 29.1%.) Domiciled in Ireland but listed in the US for tax reasons. They make things like surgical gowns, scalpels and the kinds of things that hospitals cannot do without.

biotechnology / pharmaceutical
PAST TOP PICK

(A Top Pick June 26/12. Up 28.13%.)

biotechnology / pharmaceutical
PAST TOP PICK

Recommended at $52.35 now $65.86, up 27.95% An American company based in Ireland for tax reasons. Creates health care products, used in surgery or doctors offices. They sensitive to the economy because when people aren't working they tend to put off surgeries. They are splitting off their generic drug division, which he views as a very positive move.

biotechnology / pharmaceutical
TOP PICK

(A Top Pick Dec 14/11. Up 40.38%.) Provides small medical devices and services in the ORs, so it is economically sensitive. Headquartered in Ireland for tax purposes so the stock has lagged because many view it as European company. Also, have a generic drug division and will be spinning this off near the end of the 1st half of 2013.

biotechnology / pharmaceutical
PAST TOP PICK

(A Top Pick Oct 24/11. Up 21.17%.) Hospital supply company, mostly small things that go into the operating room. Also, have a generic drug division that they are in the process of spinning out. Based in Ireland for tax reasons and is really run out of Boston.

biotechnology / pharmaceutical
TOP PICK
Cash cow. Likes health care a lot. They are in 3 different businesses. 1) Low-priced medical devices, 2) medical supplies that are used in operating rooms and 3) generic pharmaceuticals, which they will be spinning out in the next 12 months to their shareholders. They announced their intention to return 50% of their free cash flow to the shareholders. 1.3% dividend.
biotechnology / pharmaceutical
Showing 1 to 15 of 25 entries

Covidien Ltd.(COV-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Covidien Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Covidien Ltd.(COV-N) Frequently Asked Questions

What is Covidien Ltd. stock symbol?

Covidien Ltd. is a OTC stock, trading under the symbol COV-N on the (). It is usually referred to as or COV-N

Is Covidien Ltd. a buy or a sell?

In the last year, there was no coverage of Covidien Ltd. published on Stockchase.

Is Covidien Ltd. a good investment or a top pick?

Covidien Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for Covidien Ltd..

Why is Covidien Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Covidien Ltd. worth watching?

In the last year, there was no coverage of Covidien Ltd. published on Stockchase.

What is Covidien Ltd. stock price?

On , Covidien Ltd. (COV-N) stock closed at a price of $.